Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$1,142,297.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177565
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$1,305,510.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177570
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$1,375,000.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177576
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$112,231.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177566
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$575,163.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177567
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$99,000.00
Mar 1, 2023
Individual or sole proprietorship
Cystic Fibrosis Canada: Basic and Clinical Research Grants
170505
Cystic Fibrosis Canada has since its beginnings, funded high-quality CF research by Canadian researchers from across the country. We’ve always had the goal to fund the best research that will help advance our understanding of the disease and improve the lives of people with cystic fibrosis. The specific research topics were generally directed by the research interests of the scientists themselves, and by their ability to communicate well the need to fund their particular research questions.
$712,667.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177575
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$865,265.00
Apr 1, 2024
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
177568
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:
• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.
$486,460.00
Apr 30, 2018
For-profit organization
Oximetry eye Device for use in clinical environment
906429
Develop prototypes and technological capabilities at the hardware and software level for the retnia oximetry eye technology application in a clinical environment.
$49,850.00
Dec 11, 2018
For-profit organization
ARP - Lite Clinic « Cliniciel Lite »
918890
The firm wants to migrate its current Electronic Health Record system to an improved web version.